1-5 of 5
Kenneth M. Boucher
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor in Patients with Myelofibrosis Refractory or Intolerant to JAK Inhibitors

Srinivas K. Tantravahi, Soo Jin Kim, Divya Sundar, Ami B. Patel, Anthony D. Pomicter, Kenneth M. Boucher, Kamal Chamoun, Jatin Shah, Anton Rets, Tracy I. George, Josef T. Prchal, Michael W. Deininger
Journal: Blood
Blood (2021) 138 (Supplement 1): 143.
https://doi.org/10.1182/blood-2021-153940
Published: 2021
Journal Articles

The Nitric Oxide-Generating Prodrug Js-K Is Selectively Toxic Towards AML Compared to Normal Human Hematopoietic Cells

Kristi J. Smock, MD, William L. Heaton, MS, Anthony D. Pomicter, MS, Ronda A Crist, MT, Ken M Kosak, BS, Kenneth M Boucher, PhD, George M. Rodgers, MD PhD, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD, Paul J Shami, MD
Journal: Blood
Blood (2016) 128 (22): 5217.
https://doi.org/10.1182/blood.V128.22.5217.5217
Published: 2016
Journal Articles

CX-01, a Low Anticoagulant Heparin, May Enhance Count Recovery and Treatment Efficacy in Acute Myeloid Leukemia

Tibor J. Kovacsovics, MD, Alice S. Mims, MD MSCR, Mohamed E Salama, MD, Jeremy M Pantin, MD, Ken M Kosak, B.S., Narayanam Rao, PhD, Peter Ahorukomeye, Martha Glenn, MD, Michael W. Deininger, MD PhD, Kenneth M Boucher, PhD, Linda M Bavisotto, MD, Gerardo Gutierrez-Sanchez, PhD, Thomas P Kennedy, MD MPH, Stephen Garrett Marcus, MD, Paul J Shami, MD
Journal: Blood
Blood (2016) 128 (22): 5220.
https://doi.org/10.1182/blood.V128.22.5220.5220
Published: 2016
Journal Articles

Preliminary Evidence That ODSH (2-O, 3-O Desulfated Heparin) Is Safe and Enhances Count Recovery in Patients Treated with Intensive Therapy for Acute Myeloid Leukemia – Results of a Pilot Study

Tibor J. Kovacsovics, MD, Alice Mims, MD, Mohamed E Salama, MD, Jeremy M Pantin, Michael W. Deininger, Thomas P Kennedy, MD, Linda M Bavisotto, MD, Kenneth M Boucher, PhD, Stephen G Marcus, MD, Paul J Shami, MD
Journal: Blood
Blood (2014) 124 (21): 5297.
https://doi.org/10.1182/blood.V124.21.5297.5297
Published: 2014
Journal Articles

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313

Michael A. Pulsipher, Kenneth M. Boucher, Donna Wall, Haydar Frangoul, Michel Duval, Rakesh K. Goyal, Peter J. Shaw, Ann E. Haight, Michael Grimley, Stephan A. Grupp, Morris Kletzel, Richard Kadota
Journal: Blood
Blood (2009) 114 (7): 1429–1436.
https://doi.org/10.1182/blood-2009-01-196303
Published: 2009
Includes: Supplemental data